首页> 外国专利> PHARMACEUTICAL COMPOSITION COMPRISING EXTRACT OF LYSIMACHIA VULGARIS VAR. DAVURICA (LEDEB.) R.KUNTH FOR PREVENTION OR TREATMENT OF BONE DISEASES

PHARMACEUTICAL COMPOSITION COMPRISING EXTRACT OF LYSIMACHIA VULGARIS VAR. DAVURICA (LEDEB.) R.KUNTH FOR PREVENTION OR TREATMENT OF BONE DISEASES

机译:包括枸杞提取物的药物成分。 DAVURICA(LEDEB。)R.KUNTH用于预防或治疗骨病

摘要

The present invention relates to a pharmaceutical composition for preventing and treating bone diseases containing an extract of Lysimachia vulgaris var. davurica(Ledeb.) R.Kunth as an active ingredient. The extract of Lysimachia vulgaris var. davurica(Ledeb.) R.Kunth decreases expression of NFATc1 and c-Fos and inhibits activation of ERK and p38 MAPK in a differentiation process into the osteoclasts by RANKL, thereby: inhibiting differentiation into osteoclasts and bone resorption by the osteoclasts; inhibiting bone loss by LPS in a bone loss inducing animal model; and significantly reducing the number of osteoclasts. Therefore, the extract of Lysimachia vulgaris var. davurica(Ledeb.) R.Kunth can be usefully used as a composition for preventing or treating bone diseases.
机译:本发明涉及一种用于预防和治疗骨病的药物组合物,所述药物组合物包含寻常的金钱草提取物。 davurica(Ledeb。)R.Kunth作为有效成分。金钱草的提取物。 davurica(Ledeb。)R.Kunth在RANKL分化为破骨细胞的过程中,降低NFATc1和c-Fos的表达并抑制ERK和p38 MAPK的激活,从而:抑制破骨细胞的分化和破骨细胞的吸收;通过LPS抑制骨丢失的动物模型中的骨丢失;并显着减少破骨细胞的数量。因此,提取了金钱草的提取物。 davurica(Ledeb。)R.Kunth可用作预防或治疗骨病的组合物。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号